IRONWOOD PHARMACEUTICALS INC (IRWD) Stock News

USA - NASDAQ:IRWD - US46333X1081 - Common Stock

2.06 USD

+0.19 (+10.16%)

Last: 11/5/2025, 8:00:40 PM

2.0599 USD

0 (0%)

After Hours: 11/5/2025, 8:00:40 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

IRWD Latest News, Press Relases and Analysis

All

Press Releases

7 hours ago - By: Zacks Investment Research - Mentions: XNCR

Xencor (XNCR) Reports Q3 Loss, Misses Revenue Estimates

11 hours ago - By: Stocktwits - Mentions: ABBV GS

Ironwood Pharma Stock Soars After FDA Grants Approval For Irritable Bowel Syndrome Drug In Pediatric Patients

17 days ago - By: Zacks Investment Research - Mentions: XERS

Xeris Biopharma Holdings, Inc. (XERS) Hit a 52 Week High, Can the Run Continue?

a month ago - By: Benzinga - Mentions: PDEX ENTA SCYX VYGR ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

5 months ago - By: Zacks Investment Research - Mentions: ZTS

Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report?

2 months ago - By: Benzinga - Mentions: GTLB CRDO ZOOZ JEM ...

Why American Eagle Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket

3 months ago - By: Zacks Investment Research

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

3 months ago - By: Zacks Investment Research - Mentions: AZN ABBV EXAS

IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates

3 months ago - By: The Motley Fool

Ironwood (IRWD) Q2 EPS Jumps 600%

3 months ago - By: Zacks Investment Research - Mentions: PRPH

Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates

3 months ago - By: Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance

6 months ago - By: Zacks Investment Research - Mentions: AZN ABBV ANIP

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates

6 months ago - By: Stocktwits - Mentions: GS WFC

Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call

6 months ago - By: Yahoo Finance - Mentions: JNJ HD ABBV TMO ...

Is Johnson & Johnson (JNJ) the Best Dow Stock?

6 months ago - By: Zacks Investment Research - Mentions: CRON

Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates

6 months ago - By: Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals Reports First Quarter 2025 Results

6 months ago - By: Yahoo Finance - Mentions: TTWO MAT SRAD VVOS ...

Take-Two price target lowered to $236 from $240 at BMO Capital

6 months ago - By: Zacks Investment Research - Mentions: VVOS

Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

6 months ago - By: Zacks Investment Research

Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for

6 months ago - By: Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

6 months ago - By: Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance

7 months ago - By: Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

7 months ago - By: Yahoo Finance - Mentions: BMY VZ GILD VERV ...

Is Bristol-Myers Squibb Company (BMY) The Dirt Cheap Stock To Invest In Now?

7 months ago - By: Zacks Investment Research - Mentions: BIIB BMY VERV

Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News

7 months ago - By: Yahoo Finance - Mentions: NVS JNJ BIDU CXDO ...

J&J projects $400m tariff hit but raises sales outlook

7 months ago - By: Yahoo Finance - Mentions: VZ GS JNJ NVDA ...

J&J sees tariff impact from exports to China more than global imports: CFO